http://orcid.org/0000-0001-7589-1141
References
- Cotton PB, Leung JW. ERCP Chapters: 1,2,4,11. Wiley-Blackwell 2017 submitted by GastroHep.com www.gastrohep.com/ebooks/ebook.asp?book=1405120789&id=11#h123
- Adler DG, Baron TH, Davila RE, Standards of Practice Committee of American Society for Gastrointestinal Endoscopy, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62:1–8.
- Huang JQ, Bao XJ, Lu XH. The common causes and differential diagnosis of malignant jaundice. Zhonghua Nei Ke Za Zhi. 1993;32:400–404.
- Kimura Y, Takada T, Kawarada Y, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14:15–26.
- NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements. 2002;19:1–26.
- Vitale GC, Zavaleta CM. Endoscopic retrograde cholangiopancreatography for surgeons. Semin Laparosc Surg. 2003;10:19–27.
- Huang LY, Liu YX, Wu CR, et al. Application of endoscopic retrograde cholangiopancreatography in biliary-pancreatic diseases. Chin Med J (Engl). 2009;122:2967–2972.
- Rodarte-Shade M, Kahaleh M. Stent placement as a bridge to surgery in malignant biliary obstruction (pancreatic cancer, distal bile duct cancer, and hilar tumors). Gastrointest Interv. 2015;4:21–26.
- Cheng LZ, Tao Pu R, Singh C, Kuan Loong, et al. Malignant biliary obstruction: evidence of best practice. Gastroenterol Res Pract. 2016;2016:3296801.
- Morris-Stiff G, Tamijmarane A, Tan Y, et al. Pre-operative stenting is associated with a higher prevalence of post-operative complications following pancreatoduoenectomy. Int J Surg. 2011;9:145–149.
- Sudo T, Murakami Y, Uemura K, et al. Perioperative antibiotics covering bile contamination prevent abdominal infectious complications after pancreatoduodenectomy in patients with preoperative biliary drainage. World J Surg. 2014;38:2952–2959.
- Gavazzi F, Capretti G, Ridolfi C, et al. Prevention of surgical site infections after pancreaticoduodenectomy: role of preoperative biliary stent and antiibotic prohylaxis. HPB. 2016;18:e744–e745.
- Rocha FG, Shen P. Optimizing outcomes for liver and pancreas surgery. New York (NY): Springer International Publishing AG; 2018.
- Matyjas T, Pomorski L, Witas H, et al. Cholelithiasis - always infected?. Pol Przegl Chir. 2017;89:23–26.
- Neve R, Biswas S, Dhir V, et al. Bile cultures and sensitivity patterns in malignant obstructive jaundice. Indian J Gastroenterol. 2003;22:16–18.
- Yu H, Guo Z, Xing W, et al. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol. 2012;35:1136–1144.
- Qing-hui Y, Wen-tao L. Biliary tract infection and risk factors of patients with malignant obstructive jaundice. JMS. 2017;44:489.
- dos Santos JS, Junior WS, Modena I, et al. Effect of preoperative endoscopic decompression on malignant biliary obstruction and postoperative infection. Hepatogastroenterology. 2005;52:45–47.
- Mitchel J. Streptococcus mitis: walking the line between commensalism and pathogenesis. Mol Oral Microbiol. 2011; 26:89–98.
- The Human Micobiome Project Consortium. Structure, function and diversity of the healthy human micobiome. Nature. 2012;486:207–214.
- Shelburne SA, Sahasrabhojane P, Saldana M, et al. Streptococcus mitis strains causing severe clinical disease in cancer patients. Emerg Infect Dis. 2014;20:762–771.